Here are some important highlights from the meeting.
Supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc., and Actelion.
 

 

Transbronchial Cryobiopsy for the Diagnosis of ILD
Launched: November 1, 2017

 

Fleischner Society Update in Classification of IPF
Launched: November 2, 2017

 

— Dr. Paul W. Noble

— Dr. David A. Lynch

 


ICD-10 Codes and Nomenclature for Classification of PAH
Launched: November 1, 2017

 

NTM and Treatment Strategies for Patients with Cavitary Disease
Launched: November 1, 2017

 

— Dr. Ronald J. Oudiz

— Dr. Sandra G. Adams

 


Real World Experience in Patients with COPD
Launched: November 1, 2017

 

Palliative Care for Patients with IPF
Launched: November 2, 2017
 

 

— Dr. Sandra G. Adams

— Dr. Meena Kalluri

 


New Developments in the Diagnosis and Management of IPF
Launched: November 2, 2017

 

Registry Data Provide Important Severity Indicators for PH
Launched: November 1, 2017

 

— Dr. Anoop M. Nambiar

— Dr. Ronald J. Oudiz

 


The Latest in IPF: Implications for Clinical Practice
Launched: November 1, 2017

 

Perspectives on Side Effect Management
Launched: November 1, 2017
 

 

— Drs. Lisa H. Lancaster & Maria L. Padilla

— Drs. Lisa H. Lancaster & Maria L. Padilla

 


IPF Management Considerations
Launched: November 1, 2017

 

— Drs. Lisa H. Lancaster & Maria L. Padilla

 

 

 

 

 

Access other Therapeutic Areas: